News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PrimeGen Biotech Corporation and Unidym, Inc. Form Alliance to Optimize Development of Induced Pluripotent Stem Cells


3/5/2008 8:34:32 AM

IRVINE, Calif. & MENLO PARK, Calif.--(BUSINESS WIRE)--PrimeGen Biotech LLC and Unidym Inc., a majority-owned subsidiary of Arrowhead Research Corporation (NASDAQ:ARWR), today announced a corporate alliance focused on exploring new applications for carbon nanotubes in stem cell medicine. Unidym brings to this partnership its leadership in carbon nanotube science, technology and production.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES